STELLA PHARMA
NEWS
January 26th, 2026
Publication of Phase II Randomized Controlled Trial Results of BNCT for Recurrent High-Grade Meningioma in Neuro-Oncology, a journal of the Society for Neuro-Oncology
Stella Pharma Corporation announces that the results of the Phase II randomiz……
October 27th, 2025
Presentation of Domestic Phase II Clinical Trial Results for Angiosarcoma at ESMO 2025
We are pleased to announce that the detailed results of the domestic Phase II c……
October 1st, 2025
Notice Regarding the Publication of Results of a Specified Clinical Study on Boron Neutron Capture Therapy (BNCT) for Recurrent Breast Cancer Following Radiotherapy
We are pleased to announce that the final report has been published for the inv……
July 30th, 2025
Paper published: Poly(vinyl alcohol) Enhancing Therapeutic Effects of 4-L-Boronophenylalanine on Thoracic Tumors in Neutron Capture Therapy
The paper published in the International Journal of Pharmaceutics describes the……
